Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40
Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121
HouseWorks Announces Acquisition of Care and Help Home Care
HouseWorks, LLC announced on May 3 its acquisition of Care and Help Home Care. According to data captured in the LevinPro HC database, this marks the 31st Home Health & Hospice deal of 2023. This also marks HouseWorks’ second deal of the year. In February 2022, HouseWorks acquired the personal care division at Amedisys, Inc. for an undisclosed price. Amedisys was just acquired by Option Care Health in a deal valued at $3.6 billion. You can read more about that deal on the LevinPro HC platform here. Founded in 2017, Care and Help Home Care is a leading home care provider serving seniors across Philadelphia and Bucks County. In addition to its personal care services, Care and Help also... Read More »
Headlands Research Acquires Clinvest Research
Headlands Research, a portfolio company of KKR, announced on May 4 that it entered into an agreement to acquire Clinvest Research. According to data captured in the LevinPro HC database, this acquisition marks the 10th clinical trials transaction of the year. Founded in 1996, Clinvest Research has conducted more than 600 trials for chronic diseases and conditions such as headaches/migraines, arthritis and chronic pain and diabetes, as well as weight loss. Headlands is a globally integrated clinical trial site organization. The company has successfully completed more than 5,000 clinical trials. It was founded in 2018 and has 15 offices across the United States. The acquisition of... Read More »
Option Care Health to Merge With Amedisys in $3.6 Billion Deal
Option Care Health, Inc. and Amedisys, Inc. announced that they have entered into a definitive merger agreement to combine in an all-stock transaction that values Amedisys at approximately $3.6 billion, including the assumption of net debt. Upon closing, Option Care Health stockholders will own 64.5% of the combined company, and Amedisys stockholders will own 35.5%. Together, Option Care Health and Amedisys will have a national clinical workforce of more than 16,500 professionals and 674 care centers across the United States. Based on recently reported 2022 financial results, the combined company generated revenues of approximately $6.2 billion and adjusted EBITDA of approximately $622... Read More »
Provident Healthcare Partners Advises Coastal Cancer Center in OneOncology Partnership
Provident Healthcare Partners announced on May 3 it has advised Coastal Cancer Center in signing a partnership agreement with OneOncology. Coastal Cancer Center, which is led by Dr. Emily Touloukian, has six medical oncologists, a hospitalist and eight advanced practice providers. It operates out of four locations in Myrtle Beach, South Carolina. OneOncology, a portfolio company of General Atlantic, is a national network of independent community oncologists assisting partner practices to expand their cancer care services. Its network includes 850 physicians practicing at more than 180 sites, serving approximately 280,000 patients annually. The announcement follows OneOncology’s recent... Read More »
Hildred Capital Management Acquires AleraCare
New York-based private equity firm Hildred Capital Management announced on May 2 that it entered into an agreement to acquire AleraCare for an undisclosed price. AleraCare is a provider of infusion and specialty pharmacy services. Founded in 2019, AleraCare’s core lines of business includes infusions at ambulatory infusion centers, home infusion therapy, specialty pharmacy and compounding pharmacy. It has more than 35 locations in the western United States. Hildred Capital Management pursues growth equity investments in lower middle market healthcare companies with leading products, technologies and services. AleraCare will use the capital provided by Hildred to further enhance its... Read More »
Quadria Capital Acquires Majority Stake in Straits Orthopaedics
Quadria Capital has announced the acquisition of a majority stake in Straits Orthopaedics from its founder, Mr. T.H. Su, and Apex Healthcare Bhd. Kirkland & Ellis advised Quadria Capital on the debt financing for its acquisition. Under the terms of the agreement, Apex Healthcare Bhd and Su have agreed to reinvest a substantial portion of their sales proceeds back into the company as minority-stake partners. As part of the deal, Su has been reappointed as the CEO and director of the company for the next five years. Financial terms of the deal were not disclosed. Founded in 2003, Straits Orthopaedics manufactures a range of orthopedic-focused medical device solutions for blue-chip... Read More »
New Mountain Capital Acquires Apixio from Centene
New Mountain Capital announced on May 3 that it acquired Apixio Inc. from Centene Corp. for an undisclosed price. According to data captured in the LevinPro HC database, this acquisition represents the 100th eHealth transaction of the year, and the 15th in the analytics specialty. William Blair is serving as Centene’s financial adviser and Bass, Berry & Sims, PLC as its legal counsel. J.P. Morgan Securities LLC is serving as financial adviser to New Mountain Capital, and Ropes & Gray LLP is serving as its legal counsel. Apixio provides a technology suite that mines, compiles and analyzes large volumes of disparate, unstructured patient data (such as physician notes and... Read More »
Stryker Acquires Cerus Endovascular
Stryker Corp. announced on May 2 that it completed its acquisition of Cerus Endovascular Ltd. According to data captured in the LevinPro HC database, this represents the 41st Medical Devices transaction of the year. Cerus Endovascular is a privately held, commercial-stage, medical device company engaged in the design and development of neurointerventional devices for the treatment of intracranial aneurysms. Stryker develops, manufactures and markets specialty surgical and medical products. These include orthopedic implants, powered surgical instruments, endoscopic systems and patient care and handling equipment. Stryker impacts more than 130 million patients annually. Stryker’s... Read More »
Bonatra Acquires Femtech Startup MyAva
Healthcare start-up Bonatra announced on May 2 its acquisition of women’s health and wellness company MyAva for an undisclosed amount. According to data captured in the LevinPro HC database, this acquisition represents the 98th eHealth transaction of 2023, including 20 in the telehealth specialty. There were 150 eHealth and 21 telehealth deals announced between January 1, 2022, and May 2, 2022. Through this acquisition, Bonatra aims to expand its healthcare programs and become a one-stop platform for the management of chronic health conditions. Terms of the deal were not disclosed. Founded in 2019 by Evelyn Immanuel, MyAva is a femtech start-up that offers curated programs and... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
